A Novel Class of Sulfonanilides Entering Clinical Trials for Targeted Treatment of Multiple Myeloma: Dual-Mechanism Compounds Inhibiting HIF1A-Signaling and Inducing Apoptosis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hose, Dirk
  • Seckinger, Anja
  • Goldschmidt, Hartmut
  • Meissner, Tobias
  • Leber, Brian
  • Neben, Kai
  • Hillengass, Jens
  • Bertsch, Uta
  • Janssen, Bernd
  • Klein, Bernard
  • Lewis, Joe
  • Vanderkerken, Karin
  • Schultes, Christoph

publication date

  • November 19, 2010

published in